The Prevent Severe COVID-19 (PRESECO) Study
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Appili Therapeutics Inc.
- Target Recruit Count
- 1187
- Registration Number
- NCT04600895
- Locations
- πΊπΈ
Quality Professional HealthCare, Miami, Florida, United States
πΊπΈContinental Clinical Research, LLC, Miami, Florida, United States
πΊπΈSanitas Research, LLC, Miami, Florida, United States
Control of COVID-19 Outbreaks in Long Term Care
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Appili Therapeutics Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT04448119
- Locations
- π¨π¦
Mount Sinai Hospital, Toronto, Ontario, Canada
Bioavailability of ATI-1501 With Taste Test Sub Study
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- Appili Therapeutics Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03337126
- Locations
- π¨π¦
INC Research Inc., Toronto, Ontario, Canada
Β© Copyright 2024. All Rights Reserved by MedPath